CoA Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CoA Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • CoA Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • CoA Therapeutics has 11 Employees.(i)
  • CoA Therapeutics grew their employee count by 22% last year.

CoA Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is CoA Therapeutics?

CoA Therapeutics was founded in 2018 with the aim of harnessing advances in understanding of the CoA pathway to develop novel therapies for difficult to treat and rare genetic disorders. CoA Therapeutics’ approach and lead compounds are based on breakthrough scientific developments led by Suzanne Jackowski, Charles Rock and Richard Lee at St. Jude Children’s Research Hospital in Memphis, Tennessee. CoA Therapeutics is led by veteran biotechnology executives whose sole objective is to partner with patients and physicians to bring effective therapies for PKAN and other diseases to market at the soonest possible opportunity.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M11-8%N/A
#2
$15M110%N/A
#3
$1M1110%N/A
#4
$1M110%N/A
#5
$0.7M11-15%$8.6M